Becton, Dickinson and Co. (NYSE:BDX)
| CAPS Rating |
|
|---|---|
| Open | $76.51 |
| Previous Close | $76.85 |
| Daily Range | $76.04 - $76.75 |
| 52-Week Range | $69.59 - $89.75 |
| Market Cap | $16.62B |
| P/E Ratio | 12.50 |
| Dividend (Yield) | 1.80 (1.90%) |
| Volume | 1,616,022 |
| Average Daily Volume | 0 |
BDX
VS S&P 500 (SPY)
How do you think BDX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BDX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BDX News and Commentary
- What Becton, Dickinson Does With Its Cash – The Motley Fool
- Earnings Scorecard: Baxter - Analyst Blog – NASDAQ
- Earnings Scorecard: Covidien - Analyst Blog – NASDAQ
- Becton Beats, Profit Drops - Analyst Blog – NASDAQ
- Becton, Dickinson Hits Estimates, but GAAP Results Lag Last Year's – The Motley Fool
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Becton Dickinson 1Q Net Falls 17% On Higher Costs; Cuts Year View – SmartMoney
- Earnings Preview: Becton, Dickinson - Analyst Blog – NASDAQ
- Covidien's Solitaire Ok'd for Trial - Analyst Blog – NASDAQ
- Becton, Dickinson: Dividend Dynamo or Blowup? – The Motley Fool
- Covidien EPS Tops, Snips Sales View - Analyst Blog – NASDAQ
- Baxter Beats Estimates - Analyst Blog – NASDAQ
- Earnings Preview: Covidien - Analyst Blog – NASDAQ
- Earnings Preview: Baxter - Analyst Blog – NASDAQ
- Becton, Dickinson Passes This Key Test – The Motley Fool
- Meridian Intros HyperPAGE II Marker - Analyst Blog – NASDAQ
- Covidien Recalls Duet TRS - Analyst Blog – NASDAQ
- 5-Star Stocks Poised to Pop: Becton Dickinson – The Motley Fool
- Covidien Wraps up BARRX Buy - Analyst Blog – NASDAQ
- Is Becton, Dickinson's Stock Reasonable by the Numbers? – The Motley Fool
RSS Headlines
Fool UK
